Neil Kumar, the Chief Executive Officer of $BBIO ($BBIO), sold 1,875 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares. Following this trade, they now own 4,897,443 shares of $BBIO stock.
$BBIO Insider Trading Activity
$BBIO insiders have traded $BBIO stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:
- BRIAN C STEPHENSON (Secretary, Treasurer & CFO) has traded it 3 times. They made 0 purchases and 3 sales, selling 8,311 shares.
- NEIL KUMAR (Chief Executive Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 54,778 shares.
- GENETIC DISORDER L.P. KKR sold 5,800,000 shares.
- RANDAL W. SCOTT has traded it 3 times. They made 0 purchases and 3 sales, selling 2,500 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BBIO Hedge Fund Activity
We have seen 144 institutional investors add shares of $BBIO stock to their portfolio, and 136 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 5,800,000 shares (-18.7%) from their portfolio in Q3 2024
- LORD, ABBETT & CO. LLC removed 2,804,394 shares (-100.0%) from their portfolio in Q2 2024
- FARALLON CAPITAL MANAGEMENT LLC added 1,747,000 shares (+inf%) to their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP removed 1,400,524 shares (-95.3%) from their portfolio in Q3 2024
- PERCEPTIVE ADVISORS LLC removed 1,215,346 shares (-100.0%) from their portfolio in Q3 2024
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,089,492 shares (-100.0%) from their portfolio in Q3 2024
- JPMORGAN CHASE & CO added 1,040,037 shares (+590.7%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
